BioNTech Co-Founders to Launch New Venture

Ugur Sahin and Oezlem Tuereci, co-founders of BioNTech, plan to leave the company by the end of 2026 to establish a new biotech firm. BioNTech is searching for successors to ensure a smooth transition and continuation of its strategic goals.

BionTech co-founders Ugur Sahin and Oezlem Tuereci plan to depart the COVID-19 vaccine manufacturer by the close of 2026. Their decision marks the beginning of a fresh entrepreneurial journey with their new biotech company.

In response to their planned departure, the Supervisory Board of BioNTech has initiated an executive search. The move aims to identify qualified successors for Sahin and Tuereci's roles within the company. The board is committed to ensuring a smooth transition.

The upcoming changes are part of an effort to maintain seamless execution of BioNTech's strategic objectives. The company remains focused on its mission, even as it prepares for a leadership transition.